Armistice Capital »

Glaukos shares owned by Armistice Capital

Quarter-by-quarter ownership of Glaukos (GKOS) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Glaukos

Tip: Access up to 7 years of quarterly data

All positions including Glaukos held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glaukos by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $8.8M 59k 149.94

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Glaukos

BlackRock
Vanguard Group
Wellington Management Company
PRIMECAP Management Company
State Street Corporation
Ameriprise Financial
Alliancebernstein
Geode Capital Management
Westfield Capital Management Company
William Blair Investment Management
Henderson Group
Millennium Management
Capital World Investors
Braidwell
Brown Capital Management

View all funds holding Glaukos